Navigation Links
Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen

Survival Benefit Demonstrated for an AI Over Tamoxifen in a Single Trial

LUTON, UK, Friday 15 June 2007: Analysis of the entire population of a single trial has demonstrated that survival in early breast cancer can be significantly improved by switching from tamoxifen to anastrozole (Arimidex). An analysis of the 'Arimidex'-'Nolvadex 95' (ARNO 95) study, published online in The Journal of Clinical Oncology, confirms that postmenopausal women who have been taking tamoxifen as part of their treatment for early breast cancer for two years can significantly reduce the chance of their breast cancer returning by switching therapy to anastrozole.1

The ARNO 95 study, involving 979 patients, was designed to evaluate whether post-menopausal women with hormone-receptor positive early breast cancer who had been receiving endocrine treatment with tamoxifen for two years would benefit from switching to an aromatase inhibitor (AI). The study demonstrated that women switching to anastrozole (n=489) rather than remaining on tamoxifen (n= 490) experienced1: · 34% reduction in the relative risk of recurrence (HR = 0.66; p=0.049) · 47% improvement in overall survival (HR = 0.53; p=0.045) · Fewer serious adverse events (22.7% v 30.8%) (OR = 0.66; p=0.0065)

"This new study is the first individual aromatase inhibitor trial showing a benefit in overall survival in the whole of the study population. The result is particularly striking in that this was a substantial group of patients with a relatively good prognosis (74% node negative). The reason that this result is so important is that improvement in overall survival is the biggest prize of all," said Professor Jeffrey Tobias, Consultant Oncologist and Professor of Cancer medicine, University College London. "These data confirm that women who have not had the advantage of starting their adjuvant therapy with an aromatase inhibitor and are cu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
3. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
4. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
5. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
6. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
7. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
8. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
9. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
10. Once Daily, Extended-Release Ropinirole Improves Parkinsons Symptoms in Patients not Optimally Controlled With Levodopa
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

Post Your Comments:
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...lobalMarketPerspective ,, http://www.reportl...l-Market-Perspective.html ,, Risingincidenceof...onsisaprincipalfactorinfluencinggrowthinthemammogr...cancerhasallowedwomentocomeforwardfortheiryearlyma...
(Date:11/25/2009)...dingtoMillenniumResearchGroup(MRG),theglobalauthor...$3billionUSmarketfortraumafixationdeviceswillconti...ecenteconomicslowdown.MRG,s USMarketsforTraumaDevi...ydynamicoverthenextfiveyears,withcompetitorsintrod...entsofthetraumafixationmarket,fuelingmarketgrowth....
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...ends ,, http://www.reportlinker.com/p0164220...preadavailabilityofgenericdrugs,emergenceofpainman...edthepaceofgrowthinthepainmanagementmarket.Healthc...demandforservices,drugsanddevices.Themarketisprima...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Health Care Reform Could Be Obamas Toughest Challenge 49596 1Health Care Reform Could Be Obamas Toughest Challenge 49596 2Health Care Reform Could Be Obamas Toughest Challenge 49596 3Health Care Reform Could Be Obamas Toughest Challenge 49596 4Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 1Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 2Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 1Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 2Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 3
...Showed Larazotide Acetate Prevented Immunologic Ch...s with Celiac Disease, Additional Data Indicates P...ORLANDO, Fla., Oct. 7 Alba Therapeutics Corporati...s week at the American,College of Gastroenterology...tudy CLIN 1001-004, the first Phase IIa trial cond...
...DGE, Mass., Oct. 7 Taligen Therapeutics Inc.,toda...mpany,s pipeline,candidates were presented at the ...witzerland. The data highlighted the candidates, e...iated diseases., "These highlighted presentations... the conference, reveal the deep expertise and exp...
Other Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4
(Date:11/25/2009)...calEndorsements,Business,andPressJoinEfforttoEduca...re/--Onceagain,theNationalBipolarFoundationandtheM...eir"Safe,tilStable"program,whichisnowbeingwidelyac...rder.Today,theNationalBipolarFoundationreceivedapr...ilfromtheLt.GovernorofLouisianaMitchLandrieu.TheNa...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)...se blood pressure? This simple question has been ... Stress-related gene Modulates High Blood Pressure...re? This simple question has been the focus of in...as for the first time established a link between a...ponse to stress in mice as well as humans. The stu...
(Date:11/25/2009)...sed to fight rheumatoid arthritis, could help newl...EDNESDAY, Nov. 25 (HealthDay News) -- A drug commo...atoid arthritis now also shows some promise in hel.... , The drug, rituximab (Rituxan), helped patie... though the disease had destroyed some of their pa...
(Date:11/25/2009)...ss could lead mothers to overlook needed care, stu...ay News) -- A mother,s depression can worsen her c...heir six-month study of 262 black mothers and thei...ore depressive symptoms had more frequent asthma s...essive symptoms had less frequent asthma symptoms....
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
... Reynolds American,Inc. (NYSE: RAI ) will webcast...d-quarter 2008 financial results on Wednesday, Oct... Time., During the call, members of the Reynolds ...le online on a listen-only basis,at http://www.Re...
... "air burial," grave cairns, funeral mounds, mummi...ces sacred to one culture are often considered "od... example, were fascinated with the historian Herod...ontrary to the Greeks, treatment of their own dead...
...al concerns surrounding use of cells from embryos ...European researchers say they,ve figured out how t...onic-like stem cells. , The findings are the lates...acles associated with their use. , "The ability to...
...The National,Community Pharmacists Association (NC...-term incumbent representing North Carolina, for r... executive vice president and CEO of,NCPA, issued ...serve. That is why the,National Community Pharmaci...
...The National,Community Pharmacists Association (NC...m incumbent representing Arkansas, for re-election... vice president and CEO of NCPA,issued the followi...e National,Community Pharmacists Association stron...
...The National,Community Pharmacists Association (NC...rm incumbent representing Kansas, for re-election ...vice president and CEO of NCPA,issued the followin...National,Community Pharmacists Association strongl...
Other Medicine News:Health News:RAI to Webcast Third-Quarter 2008 Earnings Conference Call 2Health News:Deathways open doors to unexpected cultural practices 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 3Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 4
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
Medicine Products: